BITGF saw its Momentum Indicator move above the 0 level on November 20, 2024. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 13 similar instances where the indicator turned positive. In of the 13 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for BITGF just turned positive on November 18, 2024. Looking at past instances where BITGF's MACD turned positive, the stock continued to rise in of 17 cases over the following month. The odds of a continued upward trend are .
The Aroon Indicator for BITGF entered a downward trend on December 11, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.807) is normal, around the industry mean (23.300). P/E Ratio (33.898) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.013) settles around the average of (0.018) among similar stocks. P/S Ratio (5.260) is also within normal values, averaging (43.338).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BITGF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BITGF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.
Industry MedicalSpecialties
A.I.dvisor indicates that over the last year, BITGF has been loosely correlated with CLVSF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BITGF jumps, then CLVSF could also see price increases.
Ticker / NAME | Correlation To BITGF | 1D Price Change % | ||
---|---|---|---|---|
BITGF | 100% | N/A | ||
CLVSF - BITGF | 52% Loosely correlated | N/A | ||
VRCDF - BITGF | 22% Poorly correlated | N/A | ||
CHEOY - BITGF | 8% Poorly correlated | +0.37% | ||
BMXMF - BITGF | 1% Poorly correlated | -0.34% | ||
CBSC - BITGF | -0% Poorly correlated | N/A | ||
More |